Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
Saved in:
Main Authors: | Yafei Guo, Lingan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2019/4927083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse
by: Wen-xiong Xu, et al.
Published: (2018-01-01) -
Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
by: Robert Gish, et al.
Published: (2025-01-01) -
Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01) -
Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01) -
Elevated Serum IL-17 Expression at Cessation Associated with Graves’ Disease Relapse
by: Jianhui Li, et al.
Published: (2018-01-01)